TrialEuropean archives of psychiatry and clinical neuroscience2009

UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).

Anthony H Barnett et al.PubMed ↗Publisher ↗

No numbers read from the abstract.